"{\n    \"Title\": \"Notes to Consolidated Financial StatementsMarch 31, 2020\",\n    \"row 1\": \"12. Financial Instrument Classification\",\n    \"row 2\": \"The following table provides cost and fair value information of financial instruments by\",\n    \"row 3\": \"category. The maximum exposure to credit risk would be the carrying value as shown below.\",\n    \"row 4\": \"2020\",\n    \"row 5\": \"Fair Amortized\",\n    \"row 6\": \"Value Cost Total\",\n    \"row 7\": \"Cash $ - $12,715,377 $12,715,377\",\n    \"row 8\": \"Caldwell infant trusts 439,405 - 439,405\",\n    \"row 9\": \"Accounts receivable - 309,769 309,769\",\n    \"row 10\": \"Long-term\",\n    \"row 11\": \"investments - - -\",\n    \"row 12\": \"Investment in related\",\n    \"row 13\": \"parties - 129,252 129,252\",\n    \"row 14\": \"Accounts payable and\",\n    \"row 15\": \"accrued liabilities - 487,361 487,361\",\n    \"row 16\": \"Caldwell infant trusts\",\n    \"row 17\": \"payable 439,405 - 439,405\",\n    \"row 18\": \"S$ 878,810 $13,641,759 $14,520,569\",\n    \"row 19\": \"2019\",\n    \"row 20\": \"Fair Amortized\",\n    \"row 21\": \"Value Cost Total\",\n    \"row 22\": \"Cash S - S$ 11,689,418 S 11,689,418\",\n    \"row 23\": \"Caldwell infant trusts 274,405 - 274,405\",\n    \"row 24\": \"Accounts receivable - 195,977 195,977\",\n    \"row 25\": \"Long-term\",\n    \"row 26\": \"investments 4,159,935 - 4,159,935\",\n    \"row 27\": \"Investment in related\",\n    \"row 28\": \"parties - 115,692 115,692\",\n    \"row 29\": \"Accounts payable and\",\n    \"row 30\": \"accrued liabilities - 481,451 481,451\",\n    \"row 31\": \"Caldwell infant trusts\",\n    \"row 32\": \"payable 274,405 - 274,405\",\n    \"row 33\": \"S 4,708,745 S 12,482,538 S 17,191,283\"\n}"